Navigation Links
Nature's Bioceuticals Finalizes The Purchase of Cold and Flu Formula
Date:11/10/2011

 The FDA asked companies to stop manufacturing the 500 products within 90 days and stop shipping them within 180 days. Some manufacturers were required to stop making and shipping their products immediately.

Robert deZanger, CEO of Natures Bioceuticals stated, "We are pleased to add this spectacular natural medicine to our existing product line. Although the Cold and Flu market is flooded with a number of established brands, we are confident that we can capture a significant portion of the market with an all natural product that really works. The goal we have set is to capture 3% of the US market within a 3 year period, which could possibly generate over $100,000,000 in revenues for the company.  Our formula contains over twenty different herbs that are all 'active ingredients'. The formula provides relief from the cold and flu symptoms, but more importantly, it boosts the body's immune response to combat the cause of the virus. When taken at the onset of symptoms the formula has shown the ability to reduce the severity and duration of a cold or flu. It has also in many cases arrested the virus before symptoms are able to come to fruition. The inventor has for many years been conducting research to find a 'cure' for the common cold. This formula was invented as a result of that ongoing research. We now intend to hire an independent testing group to do a clinical trial(s) to formally document the results we have achieved and publish a report for the medical community."

About Nature's Bioceuticals:

Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associat
'/>"/>

SOURCE Nature's Bioceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
2. Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
3. Natures Bioceuticals Tears Into the Multi-Billion Dollar Chronic Kidney Disease Market
4. FDA Finalizes Regulation For Certain Software, Hardware Used With Medical Devices
5. Scott & White Finalizes College Station Land Deal
6. Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd.
7. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
8. Mindray Announces Up to $100 Million Share Repurchase Program
9. Thoratec Corporation Authorizes Additional $50 Million Share Repurchase Program
10. Elsevier Announces New 2012 Frontlist eBooks Collection on SciVerse ScienceDirect Available for Advance Purchase
11. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, Inc., ... unmet needs of severely obese patients, today announced ... beloranib, a selective inhibitor of methionine aminopeptidase 2 ... severe form of genetic obesity.  These results showed ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
(Date:4/17/2014)... of the most popular vaccine brands for children may ... be overlooking some cost factors when choosing vaccines, driving ... option, according to a new study by University of ... can be driven by numerous factors," says Sheldon H. ... of computer science and of mathematics at the U. ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... affects about one in five infants in the United ... the first several months after birth. Research into probiotic ... however, the April 1, 2014 issue of the ... a study, "Probiotics and Infant Colic," concluding that the ... infant colic did not reduce crying or fussing ...
(Date:4/17/2014)... researchers at UC Davis has shown that the cyclin ... cell division, also boosts the mitochondrial activity to power ... has been shown to perform both jobs. This newfound ... control cellular energy production, potentially advancing cancer care and ... the journal Developmental Cell . , "These proteins ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... Education Conference (I/ITSEC) has sold all its ... Center in Orlando. Occupying almost 200,000 square feet, ... simulation technology ever. The I/ITSEC Conference is ... the Orange County Convention Center in Orlando, Florida. ...
... the first robotic assisted surgery to gynaecologic cancer patient in August 2008. ... ... undergo surgery for gynaecological cancers now have an option to have surgery ... back on their feet faster while being just as effective in removing ...
... Smoked During Pregnancy More Than Twice as Likely to ... OAKLAND, Calif., Nov. 5 Babies whose mothers,smoked during ... a cleft,palate or lip as those whose mothers didn,t, ... confirms earlier findings, it is unique because it,did not ...
... Foundation Health Plan,Inc., Kaiser Foundation Hospitals and their ... for the quarter ended September,30, 2008, compared to ... KFHP/H,s operating income in the third quarter ... same quarter last year. Financial market,volatility impacted KFHP/H,s ...
... Increases 18.9% ... Recurring Diluted FAD Per Share Increases ... Third Quarter Investments Total $125 Million, NEWPORT BEACH, Calif., Nov. 4 ... investment activity for the third quarter and the nine months ended,September 30, 2008., ...
... ad has been produced by,an organization not affiliated with ... organization behind the ad., As we have stated ... other religion. But it is wrong for the Mormons ... California through the ballot box, We note Mr. ...
Cached Medicine News:Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 2Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 3Health News:Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers 2Health News:Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers 3Health News:Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers 4Health News:Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers 5Health News:Moms' Smoking Linked to Increased Risk of Birth Defects 2Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 3Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 4Health News:NHP Reports Third Quarter 2008 Earnings 2Health News:NHP Reports Third Quarter 2008 Earnings 3Health News:NHP Reports Third Quarter 2008 Earnings 4Health News:NHP Reports Third Quarter 2008 Earnings 5Health News:NHP Reports Third Quarter 2008 Earnings 6Health News:NHP Reports Third Quarter 2008 Earnings 7Health News:NHP Reports Third Quarter 2008 Earnings 8Health News:NHP Reports Third Quarter 2008 Earnings 9Health News:NHP Reports Third Quarter 2008 Earnings 10Health News:NHP Reports Third Quarter 2008 Earnings 11Health News:NHP Reports Third Quarter 2008 Earnings 12Health News:NHP Reports Third Quarter 2008 Earnings 13Health News:NHP Reports Third Quarter 2008 Earnings 14Health News:NHP Reports Third Quarter 2008 Earnings 15Health News:NHP Reports Third Quarter 2008 Earnings 16
Designed to complement Blood Bank Refrigerators, it freezers offer outstanding features, including programmable defrost times....
It includes 99 single plasma units. Model 8001 (8003), includes 11 roll-out drawers containing removable wire baskets....
Plasma Blast Chest Freezer -50C - 8098/8091 maintains a -50C (-58F) temperature to rapidly freeze single donor, apheresed, and fresh frozen plasma. Rapid freezing also preserves Factor VIII. Full loa...
... PillCam SB Capsule Endoscope is a ... the gastrointestinal tract. Natural peristalsis moves ... painlessly throughout the gastrointestinal tract, transmitting ... The procedure is ambulatory, allowing patients ...
Medicine Products: